Latest Blogs

Feb 22, 2018
During a podcast interview on leadership and change, I had the opportunity to discuss how important ASCO is in the life of a cancer doctor.
Feb 22, 2018
Dr. Evgeniya Kharchenko dreamed of creating a local society for young specialists in Russia with ASCO’s values, and made her dream a reality.
Feb 22, 2018
Case-based presentations and tumor board discussions lend additional educational opportunities to this regional conference.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and an associate professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Nov 09, 2015
Bruce cites his upbringing as the impetus to improve cancer care on a global scale. My interests are just as granular and stem from where I was born and raised, in the tiny South Pacific Island of Guam.
Oct 29, 2015
The concept of engagement leading to empowerment was a message I have heard loudly and clearly. It was a conversation brewing on social media—a cacophony of voices calling for more access, better information, more direct involvement in their care.
Oct 05, 2015
One afternoon, I was seated in front of my computer working when a ping came through, notifying me of a message delivered on Twitter. I stopped what I was doing and scrolled through Twitter and then checked my message. It was from someone I had never met in real life (“IRL,” in social media),...
Sep 29, 2015
When I became an attending at Memorial Sloan Kettering (MSKCC), I inherited a panel of patients from one of our doctors who had recently retired. One of them was Alice*, a spritely 70 year-old female. She had been diagnosed with stage III ovarian cancer in her fifties. She had surgery for it...
Sep 09, 2015
Jodi* had been diagnosed with ovarian cancer several years earlier, had received adjuvant carboplatin and paclitaxel therapy, relapsed three years later, and since then, had been on several forms of therapy—most recently receiving weekly paclitaxel. She was tolerating treatment well, but a CT scan...
Aug 31, 2015
She had come to see me as a second opinion; diagnosed with uterine serous cancer, one of the more aggressive types of uterine cancers. At surgery they found that it had metastasized to her nodes—stage III disease.

Pages